Source:http://linkedlifedata.com/resource/pubmed/id/11123330
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2001-1-3
|
pubmed:abstractText |
Despite high viral loads, T cells from sooty mangabey (SM) monkeys that are naturally infected with SIV but remain clinically asymptomatic, proliferate and demonstrate normal Ag-specific memory recall CD4(+) T cell responses. In contrast, CD4(+) T cells from rhesus macaques (RM) experimentally infected with SIV lose Ag-specific memory recall responses and develop immunological anergy. To elucidate the mechanisms for these distinct outcomes of lentiviral infection, highly enriched alloreactive CD4(+) T cells from humans, RM, and SM were anergized by TCR-only stimulation (signal 1 alone) and subsequently challenged with anti-CD3/anti-CD28 Abs (signals 1 + 2). Whereas alloreactive CD4(+)T cells from humans and RM became anergized, surprisingly, CD4(+) T cells from SM showed marked proliferation and IL-2 synthesis after restimulation. This resistance to undergo anergy was not secondary to a global deficiency in anergy induction of CD4(+) T cells from SM since incubation of CD4(+) T cells with anti-CD3 alone in the presence of rapamycin readily induced anergy in these cells. The resistance to undergo anergy was reasoned to be due to the ability of CD4(+) T cells from SM to synthesize IL-2 when incubated with anti-CD3 alone. Analysis of phosphorylated kinases involved in T cell activation showed that the activation of CD4(+) T cells by signal 1 in SM elicited a pattern of response that required both signals 1 + 2 in humans and RM. This function of CD4(+) T cells from SM may contribute to the resistance of this species to SIV-induced disease.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cyclosporine,
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/Epitopes, T-Lymphocyte,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxyurea,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Muromonab-CD3,
http://linkedlifedata.com/resource/pubmed/chemical/Sirolimus
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
166
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
506-16
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:11123330-Adult,
pubmed-meshheading:11123330-Animals,
pubmed-meshheading:11123330-Base Sequence,
pubmed-meshheading:11123330-CD4-Positive T-Lymphocytes,
pubmed-meshheading:11123330-Cells, Cultured,
pubmed-meshheading:11123330-Cercocebus atys,
pubmed-meshheading:11123330-Clonal Anergy,
pubmed-meshheading:11123330-Cyclosporine,
pubmed-meshheading:11123330-Cytokines,
pubmed-meshheading:11123330-Epitopes, T-Lymphocyte,
pubmed-meshheading:11123330-Humans,
pubmed-meshheading:11123330-Hydroxyurea,
pubmed-meshheading:11123330-Immunity, Innate,
pubmed-meshheading:11123330-Kinetics,
pubmed-meshheading:11123330-Lymphocyte Activation,
pubmed-meshheading:11123330-MAP Kinase Signaling System,
pubmed-meshheading:11123330-Macaca mulatta,
pubmed-meshheading:11123330-Mitogen-Activated Protein Kinases,
pubmed-meshheading:11123330-Molecular Sequence Data,
pubmed-meshheading:11123330-Muromonab-CD3,
pubmed-meshheading:11123330-Simian Acquired Immunodeficiency Syndrome,
pubmed-meshheading:11123330-Sirolimus
|
pubmed:year |
2001
|
pubmed:articleTitle |
Relative resistance in the development of T cell anergy in CD4+ T cells from simian immunodeficiency virus disease-resistant sooty mangabeys.
|
pubmed:affiliation |
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA. pbostik@emory.edu
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.
|